247 related articles for article (PubMed ID: 19198151)
21. Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies.
Carpo M; Pedotti R; Allaria S; Lolli F; Matà S; Cavaletti G; Protti A; Pomati S; Scarlato G; Nobile-Orazio E
J Neurol Sci; 1999 Oct; 168(2):78-84. PubMed ID: 10526187
[TBL] [Abstract][Full Text] [Related]
22. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
[TBL] [Abstract][Full Text] [Related]
23. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
Komagamine T; Yuki N
CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):391-400. PubMed ID: 16918391
[TBL] [Abstract][Full Text] [Related]
24. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.
Ho TW; Willison HJ; Nachamkin I; Li CY; Veitch J; Ung H; Wang GR; Liu RC; Cornblath DR; Asbury AK; Griffin JW; McKhann GM
Ann Neurol; 1999 Feb; 45(2):168-73. PubMed ID: 9989618
[TBL] [Abstract][Full Text] [Related]
25. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study.
Sekiguchi Y; Uncini A; Yuki N; Misawa S; Notturno F; Nasu S; Kanai K; Noto Y; Fujimaki Y; Shibuya K; Ohmori S; Sato Y; Kuwabara S
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):23-8. PubMed ID: 22010183
[TBL] [Abstract][Full Text] [Related]
26. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
[TBL] [Abstract][Full Text] [Related]
27. Anti-ganglioside complex antibodies associated with severe disability in GBS.
Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
[TBL] [Abstract][Full Text] [Related]
28. Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum.
Fukami Y; Wong AH; Funakoshi K; Safri AY; Shahrizaila N; Yuki N
Eur J Neurol; 2016 Feb; 23(2):320-6. PubMed ID: 26176883
[TBL] [Abstract][Full Text] [Related]
29. Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients.
Caudie C; Quittard Pinon A; Taravel D; Sivadon-Tardy V; Orlikowski D; Rozenberg F; Sharshar T; Raphaël JC; Gaillard JL
J Neurol; 2011 Nov; 258(11):1958-64. PubMed ID: 21516465
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of Guillain-Barré syndrome.
Hughes RA; Hadden RD; Gregson NA; Smith KJ
J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718
[TBL] [Abstract][Full Text] [Related]
31. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
[TBL] [Abstract][Full Text] [Related]
32. Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients.
Fan C; Jin H; Hao H; Gao F; Sun Y; Lu Y; Liu Y; Lv P; Cui W; Teng Y; Huang Y
Muscle Nerve; 2017 Apr; 55(4):470-475. PubMed ID: 27464289
[TBL] [Abstract][Full Text] [Related]
33. Anti-ganglioside antibody and neuropathy: review of our research.
Yuki N
J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
[TBL] [Abstract][Full Text] [Related]
35. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Kuwahara M; Suzuki S; Takada K; Kusunoki S
J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
[TBL] [Abstract][Full Text] [Related]
36. [Guillain-Barré and Fisher syndromes: update on the pathophysiological role of antiganglioside antibodies].
Kaida K
Rinsho Shinkeigaku; 2012; 52(11):914-6. PubMed ID: 23196466
[TBL] [Abstract][Full Text] [Related]
37. Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism.
Yuki N; Uncini A
Muscle Nerve; 2014 May; 49(5):629-35. PubMed ID: 24477718
[TBL] [Abstract][Full Text] [Related]
38. Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome.
Yamagishi Y; Kuwahara M; Suzuki H; Sonoo M; Kuwabara S; Yokota T; Nomura K; Chiba A; Kaji R; Kanda T; Kaida KI; Mutoh T; Yamasaki R; Takashima H; Matsui M; Nishiyama K; Sobue G; Kusunoki S
J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1339-1342. PubMed ID: 33041261
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
[TBL] [Abstract][Full Text] [Related]
40. Anti-ganglioside complex antibody profiles in a recurrent complicated case of GQ1b-seronegative miller fisher syndrome and Bickerstaff brainstem encephalitis: a case report.
Ito H; Hatanaka Y; Fukami Y; Harada Y; Kobayashi R; Okada H; Uchibori A; Chiba A; Okuda S
BMC Neurol; 2018 May; 18(1):72. PubMed ID: 29792178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
